Bayer’s Contour USB meter is integrated with Glucofacts DELUXE software for easy retrieval of data as well as longer-term tracking and analysis of blood glucose test results.
Bayer Diabetes Care today announced US Food & Drug Administ meter. Bayer’s CONTOUR USB meter is the first and only blood glucose monitor that plugs directly into a computer providing users with instant access to information that can help optimise diabetes management. The CONTOUR USB meter is integrated with Glucofacts DELUXE software for easy retrieval of data as well as longer-term tracking and analysis of blood glucose test results.
Bayer’s CONTOUR USB meter is a cutting edge, premium meter that connects directly to a PC or MAC and the meter can store up to 2,000 test results. The built-in USB technology allows patients to simply plug in to gain knowledge about trends and patterns in their blood glucose levels.
Ongoing data tracking and accurate information sharing are key to good diabetes management. The CONTOUR USB meter facilitates data organisation and management – transforming results into meaningful insights that healthcare professionals and their patients can readily discuss.
“This is an ideal blood glucose monitor for patients who are highly engaged in managing their diabetes, particularly those on insulin who must test frequently,” said David Simmons, MD, chief medical officer for Bayer Diabetes Care.
“With the CONTOUR USB meter, patients are able to review their results with their healthcare professional during an office visit, over the phone, or via email, giving them the opportunity to make treatment adjustments, such as taking action to reduce their A1C levels, if necessary.”
Measurement of A1C provides an average assessment of blood sugar levels over the past three months – and is an indicator of how well diabetes is being controlled over the longer term. Studies have shown that routine tracking of blood glucose can help patients better manage their blood sugar and may result in a lower A1C level, which is important for consistent diabetes management. In fact, even a one-percent reduction in A1C reduces the risk of serious complications by 40 percent.